All terms in DRUGBANK

Label Id Description
AVI-4065 DB05620 [AVI-4065, a phosphorodiamidate Morpholino oligomer (PMO), is an investigational antisense HCV drug. It was developed by Sarepta Therapeutics, Inc. After phase II trials it was cancelled due to lack of potency. [L2917]]
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid DB06951
4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide DB06950
N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide DB06960
5-Hydroxy-N-Propargyl-1(R)-Aminoindan DB04307
D-4-hydroxyphenylglycine DB04308
Asvasiran DB05638 [Asvasiran is an siRNA that targets the respiratory syncytial virus (RSV) N gene and inhibits viral replication. It has the potential to treat or prevent RSV infection.]
2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide DB06969
1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE) DB06968
5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine DB04306
6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE DB06967
4-O-methyl-alpha-D-glucuronic acid DB04303
Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester DB06966
L-Gluconic Acid DB04304
Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester DB06965
Glypromate DB05633 [Neuren Pharmaceuticals was developing Glypromate (glycine-proline glutamate), a naturally occurring small-molecule neuroprotectant derived from IGF-1 which inhibits caspase III dependent apoptosis, for the potential treatment of neurodegenerative diseases by IV infusion. In December 2008, the company discontinued further development of the drug after it failed to show an observable effect.]
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate DB04301
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE DB06964
4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One DB04302
3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide DB06963